https://www.marketscreener.com/quote/stock/CHINOOK-THERAPEUTICS-INC-21685619/news/Aduro-Biotech-Enters-into-Exclusive-License-Agreement-for-Proprietary-Neoantigen-Identification-Te-23718996/?utm_source=telegram&utm_medium=social&utm_campaign=share